- A Probe into the Side Effects of ADHD Drugs
The government is planning to strengthen warnings about possible psychiatric side effects from Concerta and related treatments for attention deficit hyperactivity, and is probing whether other ADHD drugs need updating, too.
- ADHD ADD Drug Adderall XR Back on the Market in Canada
Bloomberg reports Shire Says Canada Allows Sale of Adderall XR Again after appealing Health Canada's decision to pull Adderall XR from Canadian shelves.
Health Canada's decision was based on Adderall XR's link to 20 deaths.
- ADHD and Alcohol Abuse
Two new studies confirm that ADHD children are more at-risk for alcohol and substance abuse as they grow older. Parental alcoholism and stressful family environments are additional risks. Results of the two studies were published in Alcoholism: Clinical & Experimental Research [April 2007]
- ADHD Diagnosis Caution: No Test Exists to Support Chemical Imbalance Claim
"Psychiatrists are telling parents, whose children may be displaying poor behaviour, that their child has so-called ADHD due to a "chemical imbalance" in the brain. A parent would be prudent to ask the psychiatrist for evidence to support the claim of a "chemical imbalance". If they did ask however, they’d find that the evidence would not be forthcoming – as it doesn’t exist."
- ADHD Drug Treatment
Some people who need medication aren't getting it and some who don't need it are. Research says the people who use medicines the most to treat ADHD are wealthier and have better medical plans from their HMOs.
- ADHD Medications and Neurofeedback
Data from the study were used to evaluate whether stimulant medication effects physical growth in children. The data collected over three years indicates that both height and weight are decreased in children using stimulant medication.
Co-author, Professor William Pelham, of the University at Buffalo, says: "The children had a substantial decrease in their rate of growth so they weren't growing as much as other kids both in terms of their height and in terms of their weight. And the second was that there were no beneficial effects – none."
- ADHD Medications: Mayo Clinic Study Contradicts MTA Study
As I wrote earlier, the longest study actually performed while following live children was the MTA and its 3-Year Follow-up of the NIMH MTA (multi-modal treatment) recently published in the journal of the American Academy of Child and Adolescent Psychiatry.
Co-author, Professor William Pelham, of the University at Buffalo, says: "The children had a substantial decrease in their rate of growth so they weren't growing as much as other kids both in terms of their height and in terms of their weight. And the second was that there were no beneficial effects – none."
Pelham adds, "In the short run [medication] will help the child behave better, in the long run it won't. And that information should be made very clear to parents."
Here’s the most telling observation of the study: "I think that we exaggerated the beneficial impact of medication in the first study. We had thought that children medicated longer would have better outcomes. That didn't happen to be the case. There's no indication that medication's better than nothing in the long run."
- Are ADHD drugs safe? Report finds little proof
At a time when millions of children and adults are taking drugs for Attention Deficit Hyperactivity Disorder, the most comprehensive scientific analysis of the drugs to date has found little evidence that they are safe, that one drug is more effective than another or that they help school performance.
The 731-page report was done by the Drug Effectiveness Review Project, based at Oregon State University. The group analyzed 2,287 studies – virtually every investigation ever done on ADHD drugs anywhere in the world – to reach its conclusions.
- Children: Adderall and Safety
The effectiveness of ADDERALL XR for long-term use has not been systematically evaluated in controlled trials. As with other psychostimulants indicated for ADHD, there is a potential for exacerbating motor and phonic tics and Tourette's syndrome.
- Dr. Joe Biederman and ADHD
What interests me greatly is the fact that when the authors of these studies have close ties to the pharmaceutical industry, their data tends to be skewed in favor of medicine. When there isn’t a close tie, we tend to get contradictory data, which is what one would expect.
- Driving under the influence of ADHD
This is rather clever marketing as the research is funded by Shire Pharmaceuticals, the pharmaceutical mega-giant who makes Adderall and the MPH patch. As I’ve stated before, it’s always questionable when a pharmaceutical giant funds a university study on its own medications. In this instance, it will make great marketing if the good Dr. Cox finds that young adults drive better while on meds!
- Drug Updates: ADHD Drug Cylert Discontinued
The nonprofit group Public Citizen petitioned the FDA yesterday to remove Cylert -- including all generic versions of the drug -- citing an increased risk of serious liver problems and death from liver failure.
- Drug Updates: ADHD Drug Methylphenidate Linked to Chromosomal Changes
In a small but startling preliminary new study, Texas researchers have found that after just three months, every one of a dozen children treated for attention deficit/hyperactivity disorder (ADHD) with the drug methylphenidate experienced a threefold increase in levels of chromosome abnormalities-occurrences associated with increased risks of cancer and other adverse health effects.
- Girls With ADHD and ADD Are Often Overlooked
ADHD likely affects 3% to 7% of the entire child population in the US. However, girls are frequently overlooked because they often do not display hyperactive symptoms.
When teaching at the elementary level, I found this particularly true. Girls with ADHD often were simply daydreamers with poor time management skills. While some did display the outward social and behavioral problems that their male peers did, it was not very frequent.
HealthNewsDigest.com is published by the American Psychological Association. I've cited bits of this report and am alarmed by its look and feel. It reads like an endorsement and advertisement for Adderall XR.
- Hospital Begins Screening for Heart Conditions in ADHD Children
The American Heart Association’s (AHA) recent recommendation that children be screened for possible heart problems before taking ADHD stimulant medication has spurred great anxiety among parents and professionals. The recommendation was given as a response to a number of deaths due to heart failure associated with ADHD stimulant medication.
- Insurers Question Studies of ADHD Drugs
Some journals are trying themselves to help readers discover marketing messages slipped in amid the scientific data. Last year BMJ, a British journal, published a piece called "Users' guide to detecting misleading claims in clinical research reports," which came with a picture of a reader dumping salt on a medical journal. One piece of advice: Beware when the authors break out one subgroup of patients and claim benefits from the treatment that weren't evident in the whole group.
- Medication, ADHD and Heart Complications
In research published in Pediatrics, [December 2007; vol 120: pp 1494-1501], lead author, Almut G. Winterstein, PhD, assistant professor of pharmacy health care administration, University of Florida College of Pharmacy, Jacksonville, found that common stimulants used to treat attention deficit hyperactivity disorder (ADHD) don’t often cause serious heart complications in children. However, she warns that their safety is undetermined for prolonged use.
- Neurofeedback, ADHD and Medication
In his Attention Research Update, September 2007, David Rabiner, Ph.D. Senior Research Scientist, Duke University, entitled his article, How Strong is the Research Support for Neurofeedback Treatment? The report is rather perfunctory and the staid course he’s followed for years. A fresh, candid review must be performed regarding research on multi-modal treatments, neurofeedback, and medication.
- New ADHD Drug to Fix Your Child
The public's current perception is that using these medications will indeed 'fix' their broken child. Unfortunately, and according to the National Institutes of Health, more than medication is needed to address the full needs of AD/HD children. So, as long as pharmaceutical companies keep marketing in a manner which encourages the public's 'fix' perception, we'll continue to have kids who historically remove themselves from medication whenever they can (usually upon emancipation) and carry their AD/HD into adulthood with no compensatory skills.
- Pharmaceutical Makers : Follow the Money
Ever wonder why so much hoopla surrounds ADHD? The media know it's a top of mind issue for parents. However, pharmaceutical makers also know where their bread is buttered. The following article reflects the vast sums of money involved in the business of ADHD medications. Press Release Source: Research and Markets Ltd. Research and Markets: Current Global ADHD Market Is Worth $2.7Bn and is Expected to Reach $3.4Bn by 2015Tuesday June 14, 10:15 am ET DUBLIN, Ireland--(BUSINESS WIRE)--June 14, 2005--Research and Markets (http://www.researchandmarkets.com/reports/c19199) has announced the addition of Pipeline Insight: ADHD - Shire Driving Diversity in ADHD to their offering. The current ADHD market has long been saturated with traditional methylphenidate and amphetamine based drugs, with the only innovations being ...
- Questioning the growing popularity of drug treatments
Wasowicz questions the growing popularity of drug treatments as an almost reflexive action by healthcare providers. She indicates that current research shows a steady rise in the use of prescription drugs by children and adolescents, particularly among girls.
- Ritalin and Cancer
The FDA has taken an interest in the University of Texas' preliminary research regarding Ritalin and cancer. While the research is alarming, it is far too premature to be conclusive
- States sue over costly ADHD drug program
"The situation is out of control," said David Cohen, a professor at Florida International University who has been studying the use of antipsychotics since 1983. While no long-term studies have been done on the effects the drugs have on children, there is evidence children on the drugs face greater risks of diabetes, hyperglycemia and extreme weight gain, Cohen said.
The Daytona Beach Journal says, “According to a study that looked at three years of data, about 40 percent of the antipsychotics prescribed to Florida Medicaid children were given to children diagnosed with ADHD -- a use not approved by the Food and Drug Administration.”
- States sue over costly ADHD drug program
While no long-term studies have been done on the effects the drugs have on children, there is evidence children on the drugs face greater risks of diabetes, hyperglycemia and extreme weight gain, Cohen said.
- Strattera and ADHD - “Show me the money…”
The following press release makes it clear why so much attention is paid to prescribing medication to the ADHD market: MONEY. It's a $2.6 BILLION market with annual compound growth of 36.7% since 2002.
- Student Use of Stimulant Meds
Since Ritalin abuse first hit the radar screen several years ago, the reliance on prescription stimulants to enhance performance has risen, becoming almost as commonplace as No-Doz, Red Bull and maybe even caffeine. As many as 20 percent of college students have used Ritalin or Adderall to study, write papers and take exams, according to recent surveys focused on individual campuses. A study released this month by the National Center on Addiction and Substance Abuse at Columbia found that the number of teenagers who admit to abusing prescription medications tripled from 1992 to 2003, while in the general population such abuse had doubled.
- Study finds divorce increases Ritalin use in children
Children whose parents divorce are nearly twice as likely to be prescribed Ritalin in the aftermath of the split, a Canadian study reports.
What we need is a deeper understanding of this issue, at the level of the primary care practitioners," said Dr. Abel Ickowicz.
"Because . . . if we are going too quick to prescribe medication, like Ritalin, like methylphenidate, we may not only be masking the normal process of adaptation to divorce, but we may be contributing to the degree of distress the children of divorce are experiencing."
- The Evolution of ADHD, Education, and Drugs in America - Part 1
Anyone remember Dennis the Menace? As a child, I watched Jay North portray that mischievous blond-headed boy who always got into trouble and annoyed his grumpy neighbor. Dennis was loved back then.
Dennis is the kid everyone seems to have on his street even now. He’s intelligent and uses it to get into everything. Even when he tries to help others out, he still finds trouble. He often acts out without thinking about consequences.
- The Evolution of ADHD, Education, and Drugs in America - Part 2
The great industrialist and inventor, Henry Ford founded his company on precision and efficiency in the early 1900s. To produce cars for the masses, he would need a method of assembly that could quickly assemble mass produced parts into a complete automobile. His assembly line model rapidly changed the world. Using the assembly/production line model, mass assembly of products became the norm. This in turn produced higher volumes of products available to the masses. Mass production allowed manufacturers to sell products for cheaper prices as well. All of this was based on efficiency. Educationalists were impressed.
- The Evolution of ADHD, Education, and Drugs in America - Part 3
Dennis the Menace began appearing as a comic strip character in the early 1950s. While his physical appearance changed slightly in the 1960s and 1970s, he was still considered a lovable child when I began my teaching career in the mid 1980s. We continued to laugh at his innocent acts of menace toward his family and friends without mention of medication or ADHD.
- The Evolution of ADHD, Education, and Drugs in America - Part 5
As I mentioned previously, many factors were involved in the cultural shift that altered our perception about children like Dennis the Menace. The cultural shift has made the United States the leading consumer of Ritalin. As a matter of fact, according to the International Narcotics Control Board (INCB), the US now consumes about 90% of the world’s Ritalin supply!
- The Global Market For ADHD Medications
The researchers stated that one in twenty-five children is taking medication for ADHD in the US. However, their research also suggests that the diagnosis of ADHD and subsequent use of medications to control it is now spreading worldwide.
- The Last Normal Child and ADHD
Dr. Lawrence H. Diller’s book, The Last Normal Child: Essays on the Intersection of Kids, Culture, and Psychiatric Drugs, is a fascinating and provocative work. As an experienced developmental/behavioral pediatrician, Diller examines the current trend to quickly diagnose attention deficit hyperactivity disorder (ADHD) and the perfunctory prescription of stimulant drugs even when there is scarce evidence regarding academic improvement, social improvement, or long-term efficacy.
Diller’s perspective is quite evenly balanced; he prescribes stimulant medication for ADHD when indicated, but only as part of thorough assessment and comprehensive management program.
It is clear that Diller believes that ADHD is being over diagnosed. He states that over the last 15 years brand name stimulant production has increased by an astounding 1700% and generic stimulants by more than 3000%!
Register for a free